While major developed markets for biopharmaceuticals and life sciences will grow just 3 percent to 6 percent through 2014, emerging markets are expected to grow between 14 percent and 17 percent. One of these especially vital and growing markets in biopharma is China.
The U.S. needs new distribution channels and China not only has a huge demand for high-quality products, but also increased purchasing power. On the o ...
Satisfied Users & 
Approved Press Releases
